IRIS - Res&Arch Institutional Research Information System - Research & Archive

MECOCCI, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.730
EU - Europa 13.703
AS - Asia 12.755
SA - Sud America 2.365
AF - Africa 324
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 18
Totale 44.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.316
SG - Singapore 6.103
IT - Italia 3.537
BR - Brasile 1.868
IE - Irlanda 1.812
RU - Federazione Russa 1.701
HK - Hong Kong 1.659
UA - Ucraina 1.548
CN - Cina 1.460
VN - Vietnam 1.406
SE - Svezia 1.260
FR - Francia 964
DE - Germania 869
FI - Finlandia 604
KR - Corea 515
GB - Regno Unito 426
IN - India 302
AT - Austria 221
TR - Turchia 199
BD - Bangladesh 197
AR - Argentina 190
CA - Canada 186
NL - Olanda 144
MX - Messico 143
IQ - Iraq 140
PL - Polonia 135
CH - Svizzera 125
JP - Giappone 101
PK - Pakistan 99
ZA - Sudafrica 89
ES - Italia 85
UZ - Uzbekistan 79
CO - Colombia 67
EC - Ecuador 63
ID - Indonesia 63
VE - Venezuela 63
PH - Filippine 56
SA - Arabia Saudita 56
BE - Belgio 52
MY - Malesia 47
MA - Marocco 43
CZ - Repubblica Ceca 37
JO - Giordania 37
TN - Tunisia 32
CL - Cile 31
KE - Kenya 30
PY - Paraguay 29
RO - Romania 29
GR - Grecia 27
LT - Lituania 27
DZ - Algeria 25
IR - Iran 24
LB - Libano 24
AE - Emirati Arabi Uniti 23
EG - Egitto 23
NP - Nepal 20
ET - Etiopia 19
IL - Israele 19
AL - Albania 17
BO - Bolivia 17
EU - Europa 17
JM - Giamaica 17
PE - Perù 17
UY - Uruguay 16
DO - Repubblica Dominicana 15
BG - Bulgaria 13
KZ - Kazakistan 13
PS - Palestinian Territory 13
AU - Australia 12
OM - Oman 12
TH - Thailandia 12
CR - Costa Rica 11
HN - Honduras 10
AZ - Azerbaigian 9
BY - Bielorussia 8
SY - Repubblica araba siriana 8
TW - Taiwan 8
AO - Angola 7
GE - Georgia 7
HU - Ungheria 7
KG - Kirghizistan 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
MD - Moldavia 6
SN - Senegal 6
LV - Lettonia 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
TT - Trinidad e Tobago 5
TZ - Tanzania 5
AM - Armenia 4
BB - Barbados 4
BH - Bahrain 4
HR - Croazia 4
LK - Sri Lanka 4
UG - Uganda 4
Totale 44.819
Salva come PNG Salva come JPEG
Città #
Singapore 4.326
Chandler 1.967
Dublin 1.810
Hong Kong 1.654
San Jose 1.444
Ashburn 978
San Mateo 896
Jacksonville 840
Boardman 785
Dong Ket 722
Santa Clara 649
Moscow 595
Altamura 523
Seoul 496
Lauterbourg 468
Medford 466
Princeton 462
Perugia 414
Lawrence 396
Wilmington 344
Beijing 337
Los Angeles 268
Andover 266
Munich 265
Ho Chi Minh City 232
Ann Arbor 230
Piscataway 195
The Dalles 190
Rome 181
São Paulo 174
Hanoi 170
Milan 164
New York 163
Helsinki 143
Des Moines 132
Vienna 128
Frankfurt am Main 126
Saint Petersburg 121
Nuremberg 112
Norwalk 101
Turku 99
Redmond 94
Tokyo 94
Falls Church 83
Houston 77
Dallas 76
Izmir 76
Orem 76
San Paolo di Civitate 70
Warsaw 66
Brooklyn 65
Chennai 64
Chicago 62
Baghdad 61
Woodbridge 60
London 58
Montreal 58
Rio de Janeiro 56
Naples 53
Amsterdam 50
Denver 49
Toronto 49
Palermo 48
Boston 47
Brussels 45
Johannesburg 45
Redwood City 45
Atlanta 44
Bologna 44
Shanghai 43
Tashkent 43
Mexico City 41
Poplar 40
Lappeenranta 39
Belo Horizonte 38
Council Bluffs 38
Curitiba 38
Stockholm 38
Padova 37
Phoenix 37
Florence 36
Haiphong 35
Manchester 35
Brasília 34
Dearborn 34
Hefei 34
Amman 32
Bari 32
San Francisco 32
Genoa 31
Dhaka 29
Falkenstein 29
Istanbul 29
Terni 29
Lahore 28
Prato 27
Auburn Hills 25
Kraków 25
Ankara 24
Columbus 24
Totale 26.783
Salva come PNG Salva come JPEG
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.722
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 432
Musicalmente: sviluppo di un paradigma per la valutazione dell’efficacia della musicoterapia nel trattamento della demenza 237
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 191
Fracture prevention service to bridge the osteoporosis care gap 169
Antiossidanti plasmatici e longevità: studio su centenari sani 161
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 157
Antioxidants for the treatment of mild cognitive impairment. (Review) 154
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 152
Axonal injury within language network in primary progressive aphasia 152
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 151
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 151
Dementia, depression and parkinsonism: A frequent association in the elderly. 148
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 148
Platelet MAO-B activity and vitamin B12 in old age dementias. 147
Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. 146
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 142
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 142
Validation study of the Italian Addenbrooke’s Cognitive Examination Revised in a young-old and old-old population 141
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 141
Prevalence of Aging-Associated Cognitive Decline - AACD in an Italian elderly population: results from the cross sectional phase of the Italian PRoject on the Epidemiology of Alzheimer's disease (I.PR.E.A.). 139
A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks. 138
Altered mitochondrial membrane fluidity in AD brain. 135
Antibiotic use and associated factors in a large sample of hospitalised older people 134
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 133
The orthogeriatric management: an inseparable duo to foster appropriate care 132
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 131
Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature 131
The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults 131
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation 130
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 129
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 128
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 127
Blood pressure and functional aspects of the aging brain. 127
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease 127
Normative data for the ACE-R in an Italian population sample. 127
Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project 127
Oxidative stress and dementia: new perspectives in AD pathogenesis. 126
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 126
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 126
Antioxidant profile and early outcome in stroke patients. 126
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 126
Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons 124
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 123
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease 123
Attività dell'Aconitasi Mitocondriale nella demenza di Alzheimer e nel Mild cognitive impairment 123
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 123
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 122
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 122
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 121
miRNAs and Alzheimer's Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population 120
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 120
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 120
Effects of weekly supplementation of cholecalciferol and calcifediol among the oldest-old people: Findings from a randomized pragmatic clinical trial 119
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort 118
Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer’s disease 118
Antioxidant agents in Alzheimer’s disease 118
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 118
Predicting progression of Alzheimer's disease using ordinal regression 117
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 117
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status : Results from the Zincage Project. 117
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 116
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts 116
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey 116
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 116
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 116
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 115
Beta-carotene, telomerase activity and Alzheimer’s disease in old age subjects 115
Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic MCI: Results from the ReGAl project. 114
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 114
An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients 114
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 114
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 114
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 114
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 113
Gli effetti dell’anemia e dell’emotrasfusione sugli indicatori clinici nel paziente anziano con frattura di femore. 113
Detecting frontotemporal dementia syndromes using MRI biomarkers 113
Metabolic Score for Insulin Resistance (METS-IR) and Circulating Cytokines in Older Persons: The Role of Gender and Body Mass Index 112
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer disease and mild cognitive impairment 112
The “Artwork Effect” paradigm: A model for planning and assessing cognitive stimulation for people with dementia through museum visits 112
Music Therapy Effects in People with Dementia 112
Nutraceuticals in cognitive impairment and Alzheimer's disease 112
cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders 112
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 111
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. 111
Common genetic variants influence human subcortical brain structures. 111
Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. 111
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 110
Insight, cognition and quality of life in Alzheimer's disease. 110
Is multi-infarct dementia representative of vascular dementias? A retrospective study 110
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 110
The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly 110
Automatically computed rating scales from MRI for patients with cognitive disorders 110
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 110
Emotional and psychological distress of persons involved in the care of patients with Alzheimer disease predicts falls and fractures in their care recipients. 110
Approccio diagnostico ai disturbi cognitivi in corso di patologie somatiche nell’anziano. 109
Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder 109
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 108
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer disease patients and aged controls. 108
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. 108
Totale 14.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.441 0 0 0 0 0 0 0 0 0 334 316 791
2021/20223.850 158 685 128 245 137 70 71 1.126 120 121 447 542
2022/20236.909 500 1.374 76 526 534 694 89 341 2.427 55 204 89
2023/20242.969 204 331 156 97 29 26 476 130 424 122 499 475
2024/20257.495 186 741 328 179 777 367 419 599 1.670 545 1.024 660
2025/202616.457 1.300 1.305 983 2.176 2.070 1.515 3.060 1.101 1.870 1.077 0 0
Totale 46.312